Share Name Share Symbol Market Type Share ISIN Share Description
North American Banks Fund LSE:NAM London Ordinary Share GB00B15MQH61 ORD USD0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 154.00p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 -2.8 -0.7 - 5.85

North American Banks Fund (NAM) Latest News

Real-Time news about North American (London Stock Exchange): 0 recent articles
More North American Banks Fund News
North American Banks Fund Takeover Rumours

North American Banks Fund (NAM) Share Charts

1 Year North American Banks Fund Chart

1 Year North American Banks Fund Chart

1 Month North American Banks Fund Chart

1 Month North American Banks Fund Chart

Intraday North American Banks Fund Chart

Intraday North American Banks Fund Chart

North American Banks Fund (NAM) Discussions and Chat

North American Banks Fund Forums and Chat

Date Time Title Posts
23/10/200611:10Neo Alliance : Gold oz. in China, + already producing !2.00
04/6/200110:11An Investment opportunity5.00
07/3/200112:38Nycomed director sells1.00
06/2/200120:34Nycomed looking a little unhealthy6.00

Add a New Thread

North American Banks Fund (NAM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all North American Banks Fund trades in real-time

North American Banks Fund (NAM) Top Chat Posts

DateSubject
23/10/2006
11:10
energyi: Last Updated: 10/23/2006 Symbol: NAM Exchange: TSX Venture Current Share Price: $0.52 Shares Outstanding: 32.6 million Shares Fully Diluted: 46.5 million 52 Week Range (Lo - Hi): $0.30 - 0.62 Market Capitalization: $16.952 million = = SUBJECT: Toronto Resource Investment Conference Posted By: pyoing Post Time: 9/25/2006 22:28 I attended the conference and listened to the Nam corporate presentation given by Tommy Cheng CEO. Most of what Tommy spoke is already on their website, but there were a few additions that some may find useful. - there will be a NI43-101 due out November. - 2007: 10,000oz. gold to be poured, with an additional 5,000oz. from newly acquired properties. - US. OTC.BB listing is not being considered by NAM, but in the future the company does want to graduate from the Frankfurt onto Hong Kong exchange. - over a $million in the kitty. 2/ SUBJECT: RE: Toronto Resource Investment Conference Posted By: joemanner Post Time: 9/25/2006 22:42 The conference is informative to me as they have some new exciting projects due to have news coming out soon. I found out a new surge on projects on China after reading the Northern Miner issue on the China/ Mongolia. NAM is definitely among one of them as it has featured, not bad for a Company only listed for less than 6 months! 3/ SUBJECT: RE: Toronto Resource Investment Conference Posted By: BillyMiner Post Time: 9/28/2006 15:38 I spoke to the guys at the show as well. NAM has poured 400 oz of gold already from the Majiahe Property and will most likely get about 2000 oz in total from that project this year. As Pyoing said, they will get another 10,000 oz next year. The newly acquired property will also have production. They have an amazing exploration property (Xuefeng Property) with huge potential and they are currently working on a 43-101 for it. I got the feeling that they are also looking at some other properties to acquire as well. This company has awesome potential for the short and long term. Billy
06/10/2000
08:36
derek wild: Trouble seems to be nigh for Nycomed Amersham. The healthcare company's shares are on the slippery slope and, since closing at 700p early in July, they have lost 10pc. They finished at 629p, down 14p, yesterday, but CSFB reckons they should be trading at nearer 429p. "The problem is the next year's Nasdaq listing of a 10pc stake in APBiotech, its life sciences venture with Pharmacia, of the US," says the Guardian. "Earlier this week, Nycomed filed registration documents for the float with the US regulators that forced it to disclose the previously unavailable divisional profitability of APB. "After inspection of the documents, CSFB has concluded that APB is significantly less profitable than its closest rival, Applied Biosystems. CSFB reckons Nycomed's 45pc stake in APB is worth no more than 242p. Combined with the rest of the Nycomed operations, CSFB finds it hard to justify a share price higher than 443p and is advising its clients to sell."
North American Banks Fund share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20161211 13:56:41